AIDS Weekly articles from April 1994

AIDS Weekly archives from April 1994

Longer survival seen in those who delay antiretroviral therapy.
April 4, 1994... Drug Therapies While HIV-positive patients receiving antiretroviral therapy (ART) before the onset of AIDS survived longer than patients who received none, patients receiving ART only after the onset of AIDS survived even longer,...

Burroughs Wellcome: "quality of life" in patients receiving retrovir. (Burroughs Wellcome Co.)
April 4, 1994... Zidovudine Therapy The following was released by Burroughs Wellcome Company, March 17, 1994: The fundamental strategy behind treating HIV-infected individuals with Retrovir brand zidovudine (AZT) prior to the onset of AIDS is to...

Informal survey finds anti-gay bias, homophobia in medical profession.
April 4, 1994... Sexuality and AIDS An informal survey of gay and heterosexual British physicians found homophobia and anti-gay bias to be strong within the medical community ("Homophobia among Doctors," British Medical Journal, February 26,...

Reno allows HIV-positive athletes to attend Gay Games. (Janet Reno; Gay Games IV, New York)
April 4, 1994... Gay Issues U.S. Attorney General Janet Reno has temporarily lifted the U.S. entry ban to allow HIV-positive athletes to participate in the Gay Games IV in New York in the summer of 1994, the U.S. Justice Department said. Reno...

Women & AIDS Project links HIV risk to violence against women.
April 4, 1994... Women's Health Issues An Edmonton, Alberta-based project to prevent the spread of HIV among women links the risk of HIV infection to a woman's lack of power and control in an abusive relationship, identifying it as another form of...

Effectiveness of testing depends on seroprevalence rate, study finds.
April 4, 1994... Testing The cost-effectiveness of one-time HIV testing of healthcare professionals is highly dependent on the seroprevalence of infection and the degree of risk of transmission, according to "The Cost-Effectiveness of HIV Testing of...

High HIV prevalence rate found in British emergency room.
April 4, 1994... HIV and Emergency Medicine Researchers in London recently reported finding a high prevalence of HIV-1 infection among the patients of an inner city hospital's emergency department ("Prevalence of HIV Infection in Patients Attending an...

Benzodiazepine use correlates with HIV risk behavior.
April 4, 1994... Drug Abuse and HIV/AIDS An Australian study of intravenous drug users (IDUs) participating in a methadone maintenance (MM) program found that those who used benzodiazepines were more likely to have recently engaged in HIV risk behaviors...

Home healthcare services underused by HIV/AIDS patients.
April 4, 1994... Treatment Options Although home healthcare services constitute a cost -effective way to manage HIV/AIDS, a survey of patients in Ohio found that these services are underused by the majority ("Utilization of Home Health Care Services in...

Biomune Systems Inc. announces results of independent tests.
April 4, 1994... Opportunistic Infections Biomune Systems Inc., Salt Lake City, Utah, announced the results of independent tests conducted to determine the effectiveness of Biomune's drug, Immuno-C, in the treatment and eradication of cryptosporidiosis....

Trinity Biotech announces preliminary results on SeroCard HIV-1/2 test.
April 4, 1994... WHO Clinical Trials Trinity Biotech, Dublin, Ireland, announced results of a clinical trial on the company's rapid SeroCard HIV -1/2 test, reported by the Institute of Tropical Medicine, a World Health Organization (WHO) collaborating...

AIDS patients fight against stigma. (Zambia)
April 4, 1994... Zambia An AIDS patient announced his intention to contest Zambia's 1996 legislative elections - a move aimed to encourage other patients to lead positive lives. "I have always wanted to be a politician and I feel I can deliver the...

Screening of surgeons of little value to patients. (HIV Testing)
April 4, 1994... HIV Testing A Monte Carlo simulation performed in a recent study demonstrated that testing surgeons for HIV infection would do little to protect their patients from possible transmission ("Screening Surgeons for HIV Infection: Assessment...

CDC releases updated dental infection control kit. (US Centers for Disease Control and Prevention)
April 4, 1994... Educational Materials The U.S. Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, has issued an updated version of its kit for dental practice infection control, entitled Dental Infection Control File, 1993. The...

Study looks at habits of individual addicts and HIV.
April 4, 1994... Drug Abuse Intravenous drug users who stopped sharing needles greatly reduced their chances of getting HIV, according to the first study to look at the habits of individual addicts. Unlike other studies that have cited...

80,000 U.S. children motherless by end of century. (Orphan Project)
April 4, 1994... Orphan Project AIDS will leave more than 80,000 American children motherless by the end of this century, about 50,000 of them in just six cities, researchers estimated. By the year 2000, the HIV epidemic will have killed the mothers...

High prevalence of HIV-1 found among laboratory specimens.
April 4, 1994... HIV-1 Regardless of the perceived risk of HIV-1 infection, the need for universal precautions needs emphasis, indicated researchers from the U.S. Centers for Disease Control and Prevention (CDC), Atlanta, Georgia. CDC researchers...

Ethambutol should be added to TB regimen in some. (tuberculosis)
April 4, 1994... Tuberculosis In areas with high rates of Mycobacterium kansasii, ethambutol should be added to the usual regimen for suspected tuberculosis (TB) in HIV-infected persons. Since the beginning of the AIDS epidemic, M. kansasii has been...

Sexual transmission of AZT-resistance HIV-1 documented. (zidovudine)
April 4, 1994... Drug Resistance Swedish researchers report that zidovudine-resistance appears to be selected against during sexual transmission of human immunodeficiency virus type 1 (HIV-1). Initially, zidovudine treatment was given only to...

Human gene therapy trial to treat HIV begins.
April 4, 1994... Gene Therapy University of California, San Diego (UCSD) School of Medicine researchers have begun testing a gene therapy to fight HIV infection. This is the first human gene therapy trial at UCSD. The experimental therapy augments...

Scientists lay groundwork for vaccine for everything.
April 4, 1994... Vaccine Technology In a first step toward possible inoculations for virtually any virus, scientists reported developing a prototype vaccine technology that uses tiny diamond particles to induce immunity. The researchers found that...

PCR useful in extrapulmonary TB. (polymerase chain reaction; tuberculosis)
April 4, 1994... Diagnosis A study from the Catholic University of Chile finds that polymerase chain reaction (PCR) is a valid alternative to established diagnostic procedures in extrapulmonary tuberculosis (TB). The diagnosis of extrapulmonary TB...

Agency to update TRAx CD4 FDA submission with additional data. (T Cell Sciences Inc.; US Food and Drug Administration)
April 4, 1994... T Cell Sciences, Inc. T Cell Sciences, Inc., Cambridge, Massachusetts, announced as part of its continuing 510k application to the U.S. Food and Drug Administration (FDA) for TRAx CD4, that the company has agreed to undertake an...

HIV-2-infected children have improved survival. (Cote d'Ivoire)
April 4, 1994... C*te d'Ivoire Maternal infection with HIV-2 has less influence on childhood survival than infection with HIV-1, according to a report from the C*te d'Ivoire and the U.S. Centers for Disease Control and Prevention (CDC), Atlanta, Georgia...

ELISA not sensitive in the diagnosis of HIV-positive TB. (enzyme-linked immunosorbent assay; tuberculosis)
April 4, 1994... Diagnosis Enzyme-linked immunosorbent assay (ELISA) testing appears to have little sensitivity in HIV-positive tuberculosis (TB) patients. A study examining the sensitivity of the diagnostic test in both HIV-positive and...

Two cases of miliary TB of the skin reported. (tuberculosis)
April 4, 1994... HIV Two cases of miliary tuberculosis (TB) of the skin among patients with HIV infection have been reported by researchers from London's Chelsea and Westminister Hospital. Miliary TB of the skin (tuberculosis cutis miliaris...

New initiative launched. (HIV Prevention)
April 4, 1994... HIV Prevention A broad new initiative to assess and improve HIV prevention efforts across the U.S. is being launched by the Kaiser Family Foundation, the Harvard AIDS Institute, the Center for AIDS Prevention Studies at the University of...

Medical College of Wisconsin designated national center for AIDS research.
April 4, 1994... Funding The Medical College of Wisconsin, Milwaukee, has been awarded $4 million by the U.S. National Institute of Mental Health to establish a new Center for AIDS Intervention Research (CAIR). The award, announced by Wisconsin Senators...

Oracle Diagnostics new saliva test for HIV passes pre-clinical trials. (California)
April 4, 1994... California A new saliva test for HIV has successfully passed its first independent pre-clinical trials, paving the way for distribution of a simple "dipstick" test that will make AIDS screening practical and affordable to millions...

New HIV/AIDS manual available for planners.
April 4, 1994... Educational Materials A new manual titled "Joining the Fight: How to Establish an HIV/AIDS Initiative in Your Community" has been published by Sierra Health Foundation and is available, free, to interested groups. The manual is...

Duress clause removed from HIV+ compensation package. (Canada)
April 4, 1994... Canada HIV-positive claimants eligible to receive compensation under the terms of the multi -provincial/territorial assistance package (MPTAP) will no longer be required to have their lawyers sign a certificate attesting that they were...

Vivid statistics. (Graphic Report)
April 4, 1994... As of June 30, 1993, a total of 718,894 AIDS cases have been reported to the World Health Organization (WHO). The following statistics are gathered from countries reporting significant numbers only. A breakdown of reported cases was compiled...

New drug application for fluconazole for fungal infections. (Outcomes Report)(Then: AIDS Weekly, March 20, 1989)
April 4, 1994... Pfizer Inc., New York, has announced it has filed a New Drug Application (NDA) for fluconazole for the prevention and treatment of serious fungal infections in immunocompromised patients, such as cancer and AIDS patients and organ transplant...

Azole resistance common in AIDS patients. (Outcomes Report)(Now: AIDS Weekly, January 17, 1994)
April 4, 1994... Azole resistance of oropharyngeal yeasts is a common problem in patients infected with HIV-1, and this resistance has clinical relevance, according to a study from North Carolina's Duke University Medical Center. Candida species, particularly...

Gynecological care of the HIV-infected woman. (Research Report)
April 4, 1994... AUTHORS: J.M. Gormley and T.C. Fiore. Miriam Hospital, Brown University AIDS Program, Providence, Rhode Island. According to an abstract submitted by the authors to the HIV/AIDS Nursing Care Summit, held January 27-29, 1994, in...

Community-based HIV+ nurse case management/primary care project. (Research Report)
April 4, 1994... AUTHORS: B.B. Maddux and B. Pilon. Vanderbilt University, School of Nursing, Nashville, Tennessee. According to an abstract submitted by the authors to the HIV/AIDS Nursing Care Summit, held January 27-29, 1994, in Washington, D.C.,...

Women's fear of disclosing their HIV+ status. (Research Report)
April 4, 1994... AUTHORS: C. Ortiz. University of California, School of Nursing, San Francisco, California. According to an abstract submitted by the author to the HIV/AIDS Nursing Care Summit, held January 27-29, 1994, in Washington, D.C.,...

Problem-focused coping and related factors in mothers infected with HIV. (Research Report)
April 4, 1994... AUTHORS: N.C. Sharts-Nopko 1, M.J. Regan-Rubinski 2, M.A. Heverly 3, P. Lincoln 4. 1Villanova University, Villanova, Pennsylvania; 2University of Pittsburgh, Pittsburg, Pennsylvania; 3Delaware County Community College, Media, Pennsylvania;...

Home follow-up care for children who are HIV+ and their families. (Research Report)
April 4, 1994... AUTHORS: J.A. Deatrick, F. Thurber, L. DiGimarino, R. Rutstein, M.E. Cameron and H. Carlino. University of Pennsylvania, School of Nursing, Philadelphia, Pennsylvania; and Children's Hospital, Philadelphia, Pennsylvania. According to an...

Watson's theory and the nursing care needs of AIDS clients. (Research Report)
April 4, 1994... AUTHORS: I.L. Mullins. Auburn University, School of Nursing, Auburn, Alabama. According to an abstract submitted by the author to the HIV/AIDS Nursing Care Summit, held January 27-29, 1994, in Washington, D.C., "Watson's theory of...

Roles of conformational and glycan-dependent epitopes of HIV-1 gp120 in virus neutralization. (Research Report)
April 4, 1994... AUTHORS: A. Pinter 1, S. Kayman 1, Z. Wu 1, W. Honnen 1, H. Chen 1, J. McKeating 2, C. Shotten 3, S. Warrier 1 and S. Tilley 1. 1Public Health Research Institute, New York, New York; 2Reading University, Reading, United Kingdom; and...

Interactions of substrates and inhibitors with a family HIV-1 and HIV-2 homo- and heterodimeric proteinases. (Periodical Report) (Abstract)
April 4, 1994... SOURCE: Journal of Biological Chemistry, February 18, 1994;269(7):4787-4793. According to the authors' abstract of an article published in the Journal of Biological Chemistry, "Genes were constructed to encode single-chain tethered...

Purification and characterization of simian immunodeficiency virus (SIVmac) envelope glycoprotein gp130 from virus-infected cells. (Periodical Report) (Abstract)
April 4, 1994... SOURCE: Vaccine, March 1994;12(3):250-258. According to the authors' abstract of an article published in Vaccine, "A non-denaturing method has been developed for the purification of the envelope glycoprotein gp130 of the simian...

Catalytically distinct conformations of the ribonuclease H of HIV-1 reverse transcriptase by substrate cleavage patterns and inhibition by azidothymidylate and N-ethylmaleimide. (Periodical Report) (Abstract)
April 4, 1994... SOURCE: Biochemistry, February 15, 1994;33(6):1366 -1372. According to the authors' abstract of an article published in Biochemistry, "The RNase H activity of recombinant HIV-1 reverse transcriptase (RT) has been characterized with...

A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. (Periodical Reports) (Abstract)
April 4, 1994... SOURCE: Proceedings of the National Academy of Sciences of the United States of America, February 15, 1994;91(4):1256-1260. According to the authors' abstract of an article published in Proceedings of the National Academy of Sciences...

Analysis of the T-cell receptor beta-chain variable-region (V-beta) repertoire in monozygotic twins discordant for human immunodeficiency virus - evidence for perturbations of specific V-beta segments in CD4+ T cells of the virus-positive twins. (Periodical Report) (Abstract)
April 4, 1994... SOURCE: Proceedings of the National Academy of Sciences of the United States of America, February 15, 1994;91(4):1529-1533. According to the authors' abstract of an article published in Proceedings of the National Academy of Sciences...

Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. (Periodical Report) (Abstract)
April 4, 1994... SOURCE: Proceedings of the National Academy of Sciences of the United States of America, February 15, 1994;91(4):1544-1548. According to the authors' abstract of an article published in Proceedings of the National Academy of Sciences...

Effect of a thiobenzimidazolone derivative on DNA strand transfer catalyzed by HIV-1 reverse transcriptase. (Periodical Report) (Abstract)
April 4, 1994... SOURCE: Journal of Biological Chemistry, February 11, 1994;269(6):4110-4115. According to the authors' abstract of an article published in the Journal of Biological Chemistry, "Thiobenzimidazolone (TIBO) derivatives are known...

French blood test misses some HIV. (HIV-1, group O)
April 11, 1994... Rare HIV Strain A rare strain of HIV wasn't detected by a blood test used in France, U.S. health authorities said. They said the strain is found almost exclusively in patients from Cameroon and poses little risk elsewhere. No...

NIAID urged to approve Genentech HIV vaccine trial. (National Institute of Allergy and Infectious Diseases)(Donald P. Francis address) (Second Annual Conference on Vaccines)
April 11, 1994... Conference Coverage The former CDC researcher who became a hero for urging rapid government action in early days of the AIDS epidemic now calls for immediate efficacy trials of HIV vaccines. In his controversial days with the U.S....

Safety - but not efficacy - seen in clinical trials. (Second Annual Conference on Vaccines)
April 11, 1994... HIV Vaccines Despite encouraging safety data, clinical trials of HIV vaccines have not demonstrated the ability to stimulate antibodies that can neutralize virus found in infected individuals, according to a senior researcher in the...

Behavioral bias complicates trials of HIV vaccines. (Second Annual Conference on Vaccines)
April 11, 1994... Behavioral biases pose both practical and ethical dilemmas for clinical trials of HIV vaccines, according to a researcher at the U.S. National Institute of Allergy and Infectious Diseases (NIAID) Division of AIDS (DAIDS). Several...

Salk presses case for CMI-inducing HIV vaccine. (Jonas Salk; cell-mediated immunity) (Second Annual Conference on Vaccines)
April 11, 1994... Vaccine pioneer Jonas Salk has proposed a radical change in thinking about HIV vaccines. In a presentation to the Second Annual Conference on Vaccines, held March 21-23, 1994, in Alexandria, Virginia, Salk argued that current approaches...

Induction of mucosal immunity could slow HIV transmission. (Second Annual Conference on Vaccines)
April 11, 1994... A vaccine that could stimulate even a partially effective anti-HIV mucosal immune response could help stop transmission of the virus, according to researcher Bruce D. Forrest of United Biomedical Inc., Hauppage, New York. Despite major...

Decoy epitopes: a pathogenic mechanism for vaccine resistance. (Second Annual Conference on Vaccines)
April 11, 1994... HIV and other vaccine-resistant pathogens use immunodominant decoy epitopes - "decotopes" - to fool the immune system into making useless antibodies, according to the head of the Virus Biology Section of the U.S. National Cancer Institute...

WHO AIDS chief says HIV vaccine will slow search for AIDS cure. (World Health Organization; Joep Lange)
April 11, 1994... HIV infection may one day be controlled but a cure is not likely, a World Health Organization (WHO) AIDS expert told a conference in Kuwait. Joep Lange, chief of clinical research and product development for the WHO Global Program on...

New antigen is key to HIV vaccine, Swedish researcher says. (Sigvard Olofsson)
April 11, 1994... A newly discovered antigen stimulates antibodies that neutralize all known strains of HIV, according to a report in a Swedish newspaper. The newspaper Expressen quotes Sigvard Olofsson of Gothenburg University as saying, "We have found...

Researchers say AIDS advances slow but sure. (AIDS vaccine)
April 11, 1994... A vaccine to control the onset of AIDS symptoms in HIV-infected patients could be developed in five to ten years, a University of California (UC), Davis, immunologist claims. Jose Torres said at the annual conference of University of...

No HIV seroconversions found among 33 exposed healthcare workers. (Denmark)
April 11, 1994... Preliminary results of a prospective serologic follow-up study showed that no HIV seroconversions occurred among 33 occupationally exposed healthcare workers, Danish researchers reported. None of the healthcare workers was given...

Fluconazole-resistance not associated with other azole derivatives.
April 11, 1994... Fluconazole-resistant Candida albicans in HIV -positive patients does not appear to be associated with resistance to other azole derivatives. Oropharyngeal candidiasis is the most frequent opportunistic infection in patients with AIDS....

Lower risk of infections associated with tunneled placement of catheters. (AIDS-related cytomegalovirus infection)
April 11, 1994... Ganciclovir use, compared to foscarnet, in treating AIDS-related cytomegalovirus (CMV) disease was not associated with greater risk of serious catheter-related infection, stated California researchers. In patients with tunneled (versus...

Glaxo and Wellcome announce signing of letter of intent for 3TC. (Glaxo Holdings PLC, Burroughs Wellcome PLC; lamivudine)
April 11, 1994... Glaxo Holdings plc and Burroughs Wellcome plc announce the signing of a letter of intent giving Burroughs Wellcome the option to develop and market the experimental compound 3TC (generically known as lamivudine) for the treatment of HIV...

Viagene and Green Cross expand agreement. (development & commercialization of HIV ImmunoTherapeutic)
April 11, 1994... Viagene Inc., San Diego, California, announced that it has expanded its agreement with the Green Cross Corporation of Osaka, Japan, covering the development and commercialization of Viagene's HIV ImmunoTherapeutic drug. The original...

Village of sex workers is a time bomb: AIDS could spread like wildfire. (Nandlalpura, India)
April 11, 1994... In Nandlalpura, India, down a three-mile dirt track from a busy highway, every woman is or was a prostitute, and every girl child probably will become one. It is how people of the Rajnat tribe survive. Generations of Rajnat were...

Lab tests show way to block HIV infection. (antibodies for mixed connective tissue disease and systemic lupus erythematosus)
April 11, 1994... University of Southern California (USC) researchers reported their laboratory experiments indicate HIV infection may be prevented with antibodies produced in response to two autoimmune disorders. The scientists reported in the journal...

FDA approves IDE for procedure used to treat AIDS. (Food and Drug Administration; investigational device exemption; BioLogic-HT system for extracorporeal whole-body hyperthermia)
April 11, 1994... Biocontrol Technology Inc., Pittsburgh, Pennsylvania, announced that its wholly owned subsidiary, IDT Inc., in conjunction with HemoCleanse Inc. of West Lafayette, Indiana, has received approval from the U.S. Food and Drug Administration (FDA)...

Health Professionals Inc. announces Phase I trial for patients with AIDS. (Center for Special Immunology to test immune reconstitution cell-transfer therapy)
April 11, 1994... Health Professionals Inc., Fort Lauderdale, Florida, announced that its subsidiary, Center for Special Immunology (CSI), has initiated a Phase I clinical trial of its immune reconstitution cell-transfer therapy for patients with late-stage...

Study shows combination therapy safe and effective in children with HIV. (zidovudine and didanosine)
April 11, 1994... Previously untreated children with HIV who received full dose Retrovir brand zidovudine (AZT) in combination with ddI gained weight, had increased numbers of disease -fighting CD4 cells and showed decreases in viral load, according to a new...

Healthcare reform and AIDS. (in Focus: A Guide to AIDS Research and Counseling)
April 11, 1994... At best, healthcare reform will improve HIV-related care; at worst, it could sacrifice crucial services funded under existing HIV-related legislation. In the March 1994 issue of Focus: A Guide to AIDS Research and Counseling, a member of the...

HIV-positives must consume greater amounts of vitamins and minerals.
April 11, 1994... HIV-positive people must consume multiples of the recommended daily allowances (RDAs) of vitamins and minerals in order to maintain normal plasma levels of these nutrients, a recent study discloses ("Inadequate Dietary Intake and Altered...

Study examines screening for MAC bacteremia. (Mycobacterium avium complex)
April 11, 1994... Symptomatic HIV-positive patients with Mycobacterium avium complex (MAC) in their respiratory or gastrointestinal tracts stand at high risk of developing MAC bacteremia, according to a recent report ("Mycobacterium avium Complex in the...

Study finds TMP-SMX prophylactic for toxoplasmic encephalitis. (trimethoprim-sulfamethoxazole)
April 11, 1994... HIV-positive patients who are receiving trimethoprim -sulfamethoxazole (TMP-SMX) as prophylaxis for Pneumocystis carinii pneumonia (PCP) do not appear to be in need of any further prophylactic treatment for toxoplasmic encephalitis, a team of...

Poppers impair murine immune system. (nitrite inhalants)
April 11, 1994... Nitrite inhalants suppress the function of T cells in mice, according to a recent report ("T Cell Functions Are Impaired by Inhaled Isobutyl Nitrite Through a T -Independent Mechanism," Toxicology Letters, February 15, 1994;70(3):319-329). ...

Researchers find no evidence of "immunosilent" HIV. (latent infection)
April 11, 1994... Canadian researchers failed to find evidence of immunosilent HIV infection - that is, prolonged infection without seroconversion - in a cohort of 79 people who engaged in high-risk behaviors ("Absence of Prolonged Immunosilent Infection with...

British government lifts price restrictions on condoms.
April 11, 1994... Corporate Affairs Minister Neil Hamilton announced that the British government was lifting price controls on the country's largest condom supplier in a bid to increase competition and help combat the spread of AIDS. Hamilton said the...

Free information on public and private HIV-related funding opportunities. (National Association of People with AIDS)
April 11, 1994... The National Association of People with AIDS (NAPWA) has announced a new fax-on-demand system that will feature funding alerts for public and private grants related to HIV disease and AIDS. NAPWA Fax is a state -of-the-art system designed to...

Scientists find "super factory" for reading genes. (holoenzyme)
April 11, 1994... The finding of a "super factory" for reading genes should revolutionize the study of heredity and open new research avenues in cancer, infectious diseases and developmental biology, scientists said. Researchers from the Whitehead...

Dublin AIDS groups call for government funding. (Ireland)
April 11, 1994... Dublin, Ireland, has the fastest rising rate of AIDS infection among women and children in Europe, and city voluntary groups are calling on Irish authorities to provide funds to house and care for these AIDS patients and others with HIV. ...

Putting more focus in fight against AIDS. (Thailand)
April 11, 1994... Faced with a worsening AIDS crisis, the Thai government has merged two sets of guidelines into a single action plan that it hopes will limit the spread of the disease. For two years, Thailand has been formulating its policies on AIDS...

All can contract AIDS, says study. (Zambia)
April 11, 1994... A recent study by Zambia's Tropical Disease Research Center has challenged the widely-held belief in this country that health workers face a higher risk of contracting HIV than ordinary people. The World Health Organization (WHO)-funded...

Most AIDS cases result from drug injection among young inmates. (Argentina)
April 11, 1994... Argentine researchers called for infection control measures that focus on global prevention of drug addiction. More than one fourth of a group of 606 young people in security institutes of Buenos Aires, Argentina, were intravenous drug...

AIDS now challenging every aspect of Third World.
April 11, 1994... The AIDS epidemic is the most critical challenge facing the Third World and will continue to have a devastating impact into the 21st century. Currently, of the 15 million people worldwide who are infected with HIV, 90 percent are in the...

Virus-host interactions and immune responses in HIV infection. (Research Report)
April 11, 1994... AUTHORS: H. Schuitemaker, M. Klein, A. Van't Wout, L. Meyaard, M.T. Roos, P. Schellekens and F. Miedema. Red Cross Blood Transfusion Service, Central Laboratory, Amsterdam, Netherlands; and University of Amsterdam, Laboratory of Experimental...

Mechanism of CD8+ cell suppression of HIV replication. (Research Report)
April 11, 1994... AUTHORS: J.A. Levy, C.E. Mackewicz, E. Barker and D. Blackbourn. University of California, San Francisco, California. According to an abstract presented by the authors during a plenary session of the Keystone Symposia titled Prevention...